Clinical Trial Update: Window Study of ZD4054 in Metastatic Prostate Cancer [NA]

View source ↗

Summary

Clinical trial update describing a window study of ZD4054 (zibotentan) in metastatic prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ZD4054 (zibotentan)

Snippet

Sponsor: The Christie NHS Foundation Trust | Conditions: Prostate Cancer, Metastasis | NA | Status: UNKNOWN